Your browser doesn't support javascript.
loading
Effect of pioglitazone on cardiometabolic profiles and safety in patients with type 2 diabetes undergoing percutaneous coronary artery intervention: a prospective, multicenter, randomized trial.
Tanaka, Atsushi; Komukai, Sho; Shibata, Yoshisato; Yokoi, Hiroyoshi; Iwasaki, Yoshihiro; Kawasaki, Tomohiro; Horiuchi, Kenji; Nakao, Koichi; Ueno, Takafumi; Nakashima, Hitoshi; Tamashiro, Masahiro; Hikichi, Yutaka; Shimomura, Mitsuhiro; Tago, Motoko; Toyoda, Shigeru; Inoue, Teruo; Kawaguchi, Atsushi; Node, Koichi.
Afiliación
  • Tanaka A; Department of Cardiovascular Medicine, Saga University, 5-5-1 Nabeshima, Saga, Japan. tanakaa2@cc.saga-u.ac.jp.
  • Komukai S; Clinical Research Center, Saga University Hospital, Saga, Japan.
  • Shibata Y; Miyazaki Medical Association Hospital, Cardiovascular Center, Miyazaki, Japan.
  • Yokoi H; Department of Cardiology, Kokura Memorial Hospital, Kitakyushu, Japan.
  • Iwasaki Y; Department of Cardiology, Nagasaki Kouseikai Hospital, Nagasaki, Japan.
  • Kawasaki T; Department of Cardiology, Cardiovascular Center, Shin-Koga Hospital, Kurume, Japan.
  • Horiuchi K; Division of Cardiology, Saiseikai Kumamoto Hospital Cardiovascular Center, Kumamoto, Japan.
  • Nakao K; Division of Cardiology, Saiseikai Kumamoto Hospital Cardiovascular Center, Kumamoto, Japan.
  • Ueno T; Division of Cardiovascular Medicine, Department of Internal Medicine, Kurume University School of Medicine, Kurume, Japan.
  • Nakashima H; Department of Cardiology, National Hospital Organization Kagoshima Medical Center, Kagoshima, Japan.
  • Tamashiro M; Department of Cardiology, Tomishiro Central Hospital, Okinawa, Japan.
  • Hikichi Y; Department of Cardiovascular Medicine, Saga University, 5-5-1 Nabeshima, Saga, Japan.
  • Shimomura M; Department of Cardiovascular Medicine, Saga University, 5-5-1 Nabeshima, Saga, Japan.
  • Tago M; Department of Cardiovascular Medicine, Saga University, 5-5-1 Nabeshima, Saga, Japan.
  • Toyoda S; Department of Cardiovascular Medicine, Dokkyo Medical University, Mibu, Japan.
  • Inoue T; Department of Cardiovascular Medicine, Dokkyo Medical University, Mibu, Japan.
  • Kawaguchi A; Clinical Research Center, Saga University Hospital, Saga, Japan.
  • Node K; Department of Cardiovascular Medicine, Saga University, 5-5-1 Nabeshima, Saga, Japan. node@cc.saga-u.ac.jp.
Heart Vessels ; 33(9): 965-977, 2018 Sep.
Article en En | MEDLINE | ID: mdl-29487991
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad de la Arteria Coronaria / Vasos Coronarios / Tiazolidinedionas / Diabetes Mellitus Tipo 2 / Stents Liberadores de Fármacos / Lípidos Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male Idioma: En Revista: Heart Vessels Asunto de la revista: CARDIOLOGIA Año: 2018 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad de la Arteria Coronaria / Vasos Coronarios / Tiazolidinedionas / Diabetes Mellitus Tipo 2 / Stents Liberadores de Fármacos / Lípidos Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male Idioma: En Revista: Heart Vessels Asunto de la revista: CARDIOLOGIA Año: 2018 Tipo del documento: Article País de afiliación: Japón